Ptc Therapeutics (PTCT) Asset Utilization Ratio (2013 - 2026)

Ptc Therapeutics' Asset Utilization Ratio history runs 14 years deep, the most recent figure standing at 0.29 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 60.58% year-over-year to 0.29; the TTM figure through Mar 2026 stood at 0.29 (down 60.58% YoY), while the FY2025 annual figure was 0.75, up 67.78% from the prior year.
• Asset Utilization Ratio was 0.29 for Q1 2026 at Ptc Therapeutics, down from 0.62 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.73 in Q1 2025 to a low of 0.29 in Q1 2026.
• Historically, Asset Utilization Ratio has averaged 0.49 across 5 years, with a median of 0.46 in 2023.
• The sharpest annual moves came in 2022 and 2026: Asset Utilization Ratio surged 121.99% in 2022, then slumped 60.58% in 2026.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.43 in 2022, then surged by 39.58% to 0.59 in 2023, then plunged by 41.18% to 0.35 in 2024, then soared by 78.63% to 0.62 in 2025, then tumbled by 54.08% to 0.29 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.29 (Q1 2026), 0.62 (Q4 2025), and 0.67 (Q3 2025), per Business Quant data.